Co-Authors
This is a "connection" page, showing publications co-authored by J Baillie and Antonia Ho.
Connection Strength
0.695
-
Genetic mechanisms of critical illness in COVID-19. Nature. 2021 03; 591(7848):92-98.
Score: 0.229
-
Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg Health Eur. 2021 Sep; 8:100186.
Score: 0.060
-
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. Lancet. 2021 07 17; 398(10296):223-237.
Score: 0.060
-
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study. Lancet Microbe. 2021 Aug; 2(8):e354-e365.
Score: 0.059
-
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK. Lancet Respir Med. 2021 07; 9(7):773-785.
Score: 0.059
-
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity. Cell. 2021 03 04; 184(5):1171-1187.e20.
Score: 0.058
-
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study. Lancet Respir Med. 2021 04; 9(4):349-359.
Score: 0.058
-
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020 09 09; 370:m3339.
Score: 0.056
-
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020 May 22; 369:m1985.
Score: 0.055